POON CHRISTINE A sold $7.6M of REGN
POON CHRISTINE A sold 7,830 shares of REGENERON PHARMACEUTICALS, INC. (REGN) at an average of $969.09 ($966.74–$971.31, $7.59M total) across 6 trades on 2026-11-02.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider holdings, but the size relative to Regeneron's market cap suggests limited market impact.
Market read
The filing offers new information for investors monitoring insider activity, but is unlikely to drive significant price movement.
What to watch
Potential tax planning or diversification motives for the director are not disclosed.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Director Christine Poon sold 7,830 shares of Regeneron for $7.6M via open-market transactions on 2026-11-02.
likely slight downward pressure as the market prices the insider sell.
A director's $7.6M sale is material but not large enough to trigger a significant move; investors may view it as a neutral signal.
Market effects
Minimal impact on the biotech sector; the sale is company‑specific.
No broader regional effect.
Limited to Regeneron investors.
Counterpoint
The sale could be a routine liquidity event and not indicative of any negative outlook.
Key entities
- CompanyRegeneron Pharmaceuticals, Inc.
Biopharmaceutical company whose director sold shares.
- PersonChristine Poon
Director of Regeneron who executed the sale.
